GILD - Gilead Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 582.7B
Enterprise Value 383.67B
Trailing P/E 14.35
Forward P/E 19.40
PEG Ratio (5 yr expected) 15.16
Price/Sales (ttm)3.71
Price/Book (mrq)3.77
Enterprise Value/Revenue 33.75
Enterprise Value/EBITDA 67.94

Trading Information

Stock Price History

Beta (3Y Monthly) 1.15
52-Week Change 3-13.13%
S&P500 52-Week Change 36.90%
52 Week High 379.61
52 Week Low 360.32
50-Day Moving Average 366.80
200-Day Moving Average 366.23

Share Statistics

Avg Vol (3 month) 36.44M
Avg Vol (10 day) 35.22M
Shares Outstanding 51.27B
Float 1.27B
% Held by Insiders 10.70%
% Held by Institutions 182.64%
Shares Short (Jun 28, 2019) 411.9M
Short Ratio (Jun 28, 2019) 41.77
Short % of Float (Jun 28, 2019) 40.93%
Short % of Shares Outstanding (Jun 28, 2019) 40.94%
Shares Short (prior month May 31, 2019) 412.08M

Dividends & Splits

Forward Annual Dividend Rate 42.52
Forward Annual Dividend Yield 43.75%
Trailing Annual Dividend Rate 32.34
Trailing Annual Dividend Yield 33.48%
5 Year Average Dividend Yield 4N/A
Payout Ratio 451.54%
Dividend Date 3Jun 27, 2019
Ex-Dividend Date 4Jun 13, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Jan 28, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 26.40%
Operating Margin (ttm)40.79%

Management Effectiveness

Return on Assets (ttm)8.88%
Return on Equity (ttm)27.56%

Income Statement

Revenue (ttm)22.32B
Revenue Per Share (ttm)17.30
Quarterly Revenue Growth (yoy)3.80%
Gross Profit (ttm)17.27B
EBITDA 10.54B
Net Income Avi to Common (ttm)5.89B
Diluted EPS (ttm)4.53
Quarterly Earnings Growth (yoy)28.40%

Balance Sheet

Total Cash (mrq)29.01B
Total Cash Per Share (mrq)22.81
Total Debt (mrq)27.08B
Total Debt/Equity (mrq)122.59
Current Ratio (mrq)3.62
Book Value Per Share (mrq)17.23

Cash Flow Statement

Operating Cash Flow (ttm)7.57B
Levered Free Cash Flow (ttm)5.5B